HRT Financial’s Meihua International Medical Technologies MHUA Stock Holding History

HRT Financial’s Portfolio MHUA Stock Details MHUA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-334	Closed	-$11K	–	3047
2024 Q4	$11K	Buy	+334	New	+$20.5K	﹤0.01%	2269

Other funds holding MHUA

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's MHUA Position: Q1 2025 in Review

HRT Financial sold out of Meihua International Medical Technologies (MHUA) in Q1 2025, closing a stake of 334 shares — an estimated $11K sold.

HRT Financial first reported a position in MHUA in Q4 2024 and held it in 1 quarter. The position peaked at $11K in Q4 2024. 9 funds tracked by Wall St. Rank hold MHUA as of Q1 2025.

HRT Financial reported no remaining Meihua International Medical Technologies position as of Q1 2025 after selling out during the quarter.
HRT Financial sold 334 Meihua International Medical Technologies shares in Q1 2025, an estimated $11K.
HRT Financial first reported a position in Meihua International Medical Technologies in Q4 2024 and held it in 1 quarter.
HRT Financial's Meihua International Medical Technologies position peaked at $11K in Q4 2024.
9 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.